Progesterone-dependent immunomodulation

J. Szekeres-Barthó, B. Polgár, N. Kozma, E. Miko, G. Pár, L. Szereday, A. Barakonyi, T. Palkovics, O. Papp, P. Varga

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF, synthesized by lymphocytes of healthy pregnant women in the presence of progesterone, inhibits arachidonic acid release as well as NK activity, and modifies the cytokine balance. Within the cell the full-length PIBF is associated with the centrosome, while secretion of shorter forms is induced by activation of the cell. PIBF induces nuclear translocation of STAT6 as well as PKC phosphorylation and exerts a negative effect on STAT4 phosphorylation. The concentration of PIBF in pregnancy urine is related to the positive or negative outcome of pregnancy; furthermore, premature pregnancy termination is predictable by lower than normal pregnancy PIBF values. In vivo data suggest the biological importance of the above findings. Treatment of pregnant Balb/c mice with the antiprogesterone RU 486 results in an increased resorption rate, which is associated with the inability of spleen cells to produce PIBF. High resorption rates induced by progesterone receptor block as well as those due to high NK activity are corrected by simultaneous PIBF treatment.

Original languageEnglish
Pages (from-to)118-125
Number of pages8
JournalChemical Immunology and Allergy
Volume89
Publication statusPublished - 2006

Fingerprint

Immunomodulation
Progesterone
Pregnancy
Phosphorylation
Mifepristone
Centrosome
blocking factor
Progesterone Receptors
Pregnancy Outcome
Arachidonic Acid
Pregnant Women
Spleen
Urine
Lymphocytes
Cytokines

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Progesterone-dependent immunomodulation. / Szekeres-Barthó, J.; Polgár, B.; Kozma, N.; Miko, E.; Pár, G.; Szereday, L.; Barakonyi, A.; Palkovics, T.; Papp, O.; Varga, P.

In: Chemical Immunology and Allergy, Vol. 89, 2006, p. 118-125.

Research output: Contribution to journalArticle

Szekeres-Barthó, J. ; Polgár, B. ; Kozma, N. ; Miko, E. ; Pár, G. ; Szereday, L. ; Barakonyi, A. ; Palkovics, T. ; Papp, O. ; Varga, P. / Progesterone-dependent immunomodulation. In: Chemical Immunology and Allergy. 2006 ; Vol. 89. pp. 118-125.
@article{d7e7c60fa53342ce9640394176b614aa,
title = "Progesterone-dependent immunomodulation",
abstract = "The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF, synthesized by lymphocytes of healthy pregnant women in the presence of progesterone, inhibits arachidonic acid release as well as NK activity, and modifies the cytokine balance. Within the cell the full-length PIBF is associated with the centrosome, while secretion of shorter forms is induced by activation of the cell. PIBF induces nuclear translocation of STAT6 as well as PKC phosphorylation and exerts a negative effect on STAT4 phosphorylation. The concentration of PIBF in pregnancy urine is related to the positive or negative outcome of pregnancy; furthermore, premature pregnancy termination is predictable by lower than normal pregnancy PIBF values. In vivo data suggest the biological importance of the above findings. Treatment of pregnant Balb/c mice with the antiprogesterone RU 486 results in an increased resorption rate, which is associated with the inability of spleen cells to produce PIBF. High resorption rates induced by progesterone receptor block as well as those due to high NK activity are corrected by simultaneous PIBF treatment.",
author = "J. Szekeres-Barth{\'o} and B. Polg{\'a}r and N. Kozma and E. Miko and G. P{\'a}r and L. Szereday and A. Barakonyi and T. Palkovics and O. Papp and P. Varga",
year = "2006",
language = "English",
volume = "89",
pages = "118--125",
journal = "Progress in Allergy",
issn = "1660-2242",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Progesterone-dependent immunomodulation

AU - Szekeres-Barthó, J.

AU - Polgár, B.

AU - Kozma, N.

AU - Miko, E.

AU - Pár, G.

AU - Szereday, L.

AU - Barakonyi, A.

AU - Palkovics, T.

AU - Papp, O.

AU - Varga, P.

PY - 2006

Y1 - 2006

N2 - The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF, synthesized by lymphocytes of healthy pregnant women in the presence of progesterone, inhibits arachidonic acid release as well as NK activity, and modifies the cytokine balance. Within the cell the full-length PIBF is associated with the centrosome, while secretion of shorter forms is induced by activation of the cell. PIBF induces nuclear translocation of STAT6 as well as PKC phosphorylation and exerts a negative effect on STAT4 phosphorylation. The concentration of PIBF in pregnancy urine is related to the positive or negative outcome of pregnancy; furthermore, premature pregnancy termination is predictable by lower than normal pregnancy PIBF values. In vivo data suggest the biological importance of the above findings. Treatment of pregnant Balb/c mice with the antiprogesterone RU 486 results in an increased resorption rate, which is associated with the inability of spleen cells to produce PIBF. High resorption rates induced by progesterone receptor block as well as those due to high NK activity are corrected by simultaneous PIBF treatment.

AB - The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF, synthesized by lymphocytes of healthy pregnant women in the presence of progesterone, inhibits arachidonic acid release as well as NK activity, and modifies the cytokine balance. Within the cell the full-length PIBF is associated with the centrosome, while secretion of shorter forms is induced by activation of the cell. PIBF induces nuclear translocation of STAT6 as well as PKC phosphorylation and exerts a negative effect on STAT4 phosphorylation. The concentration of PIBF in pregnancy urine is related to the positive or negative outcome of pregnancy; furthermore, premature pregnancy termination is predictable by lower than normal pregnancy PIBF values. In vivo data suggest the biological importance of the above findings. Treatment of pregnant Balb/c mice with the antiprogesterone RU 486 results in an increased resorption rate, which is associated with the inability of spleen cells to produce PIBF. High resorption rates induced by progesterone receptor block as well as those due to high NK activity are corrected by simultaneous PIBF treatment.

UR - http://www.scopus.com/inward/record.url?scp=27244456055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244456055&partnerID=8YFLogxK

M3 - Article

C2 - 16129958

AN - SCOPUS:27244456055

VL - 89

SP - 118

EP - 125

JO - Progress in Allergy

JF - Progress in Allergy

SN - 1660-2242

ER -